Non alcoholic fatty liver. Fatty (change of) liver, not elsewhere classified
Conditions
Interventions
Intervention 1: Intervention group: Empagliflozine receivers with dose of 10mg po daily for 8 weeks from Abidipharma company. Intervention 2: Control group: patients in this group receive diet program
Sponsors
Yasouj University of Medical Sciences
Doosti motlagh laboratory
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Ages greater than 18 Fatty liver sonography findings ALT levels greater than 33 in non diabetic male and greater than 25 in non diabetic female Personal interest to participate Consumption of non or less than 20 grams of alcohol per day in female and non or less than 30 grams of alcohol per daY in male No history of malignancies,cardiovascular respiratory and renal complications, No history of weight loss or weight loss surgery No history of drug consumption and no history of metabolic and endocrine complications No history of liver enhancing drugs such as Vit E,Liver goal,Liver med ...
Exclusion criteria
Exclusion criteria: No interest in participating Pregnancy or breastfeeding in female No drug use compatibility Allergy to Empagliflozine Participating in other clinical studies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Alanine transaminase. Timepoint: Before the start of study and 8 weeks after intervention. Method of measurement: Calorimetry withhitachi autoanalyzer 7020. | — |
Secondary
| Measure | Time frame |
|---|---|
| C reactive protein. Timepoint: Before intervention and 8 weeks after the start of intervention. Method of measurement: Laser nephelometry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmirhossein Doostimotlagh
Yasouj University of Medical Sciences
Outcome results
None listed